The purpose of the study was to document the knowledge and awareness of HPV infection and Pap smear among the study women and to conduct screening with Pap smear cytology and HPV testing. The study also aimed to further perform a correlation analysis of HPV prevalence with demographic data.
The present study collected demographic, epidemiologic and clinical information of women of aged group 20–60 years with gynaecological abnormalities who attended the gynaecology and cancer OPD at a tertiary care health centre.
Majority of the study participants were young married ladies and did not have any formal education (85.5%). Mean (SD) age at the time of first pregnancy among the study subjects was 16.8 (2.7) years. Majority of the study participants were below poverty line (88.2%). A total of 68.6% of the study subjects had an HPV infection. Among those that had an HPV infection, majority had HPV 16 infection (95.4%). In the remaining 4.6%, HPV 18 was present. Findings show that with increasing age, HPV prevalence increases. Also, early age at marriage, lack of education, increased parity, early age at first pregnancy, poor sanitation, use of tobacco and belonging to below poverty line were significant risk factors for HPV infection in this cohort.
The study reported a high prevalence of HPV infection in rural women attending the gynaecology and cancer OPD of a tertiary care hospital. Several important risk factors for the HPV infection were also identified. These were early age at marriage, lack of education, increased parity, early age at first pregnancy, poor sanitation, use of tobacco and belonging to below poverty line. These findings call for more efforts to increase awareness pertaining to HPV infection and cervical cancer among rural women.
This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Denny L. Cervical cancer: prevention and treatment. Discov Med. 2012;14:125–31.
Satija A. Cervical cancer in India. South Asia centre for chronic disease. http://sancd.org/uploads/pdf/cervical_cancer.pdf.
Arbyn M, Castellsague X, DeSanjose S, et al. Worldwide burden of cervical cancer. Ann Oncol. 2011;22:2675–86.
Yeole BB, Kumar AV, Kurkureet A, Sunny L. Population-based survival from cancers of breast, cervix and ovary in women in Mumbai. Asian Pac J Cancer Prev. 2004;5:308–15.
ICO Information Centre on HPV and cancer (Summary Report 2014-08-22).Human Papillomavirus and Related Diseases in India. 2014.
National Cancer Control Programme. http://www.mohfw.nic.in/showfile.php?lid=324.
National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Disease and Stroke. http://www.nrhmhp.gov.in/sites/default/files/files/NCD_Guidelines.pdf.
Gakidou E, Stella N, Ziad O. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PloS Med. 2009;5:e132.
Aswathy S, Quereshi MA, Kurian B, Leelamoni K. Cervical cancer screening: current knowledge and practice among women in a rural population of Kerala, India. Indian J Med Res. 2012;136(2):205–10.
Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360:1385–94.
Sankaranarayanan R, Esmy PO, Ramkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu: a cluster-randomised trial. Lancet. 2007;370:398–406.
Dutta S, Biswas N, Mukheriee G. Evaluation of sociodemographic factors for non compliance to treatment in locally advanced cases of cancer cervix in a rural medical college hospital in India. Indian J Palliat Care. 2013;19(3):158–65.
Nandakumar A, Ramnath T, Chaturvedi M. The magnitude of cancer cervix in India. Indian J Med Res. 2009;130(3):219–21.
National Centre for Disease Informatics Research, National Cancer Registry Programme, ICMR Three Year Report of Population Based Registries, 2009–2011 Bangalore, India: NCDIR-NCRP (ICMR) 2014.
Hussain MA, Pati S, Swain S, et al. Pattern and trends of cancer in Odisha, India: a retrospective study. Asian Pac J Cancer Prev. 2012;13(12):6333–6.
Ugwu E, Obi S, Ezechukwu P, Okafor I, Ugwu A. Acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria. Niger J Clin Pract. 2013;16(2):249.
Ortashi O, Raheel H, Shalal M, Osman N. Awareness and knowledge about human papillomavirus infection and vaccination among women in UAE. Asian Pac J Cancer Prev APJCP. 2013;14(10):6077–80.
Sabeena S, Bhat PV, Kamath V, Aswathyraj S, Arunkumar G. Knowledge, attitude and practice concerning human papilloma virus infection and its health effects among rural women, Karnataka, South India. Asian Pac J Cancer Prev APJCP. 2015;16(12):5053–8.
Kulkarni SS, Kulkarni SS, Vastrad PP, et al. Prevalence and distribution of high risk human papillomavirus (HPV) Types 16 and 18 in Carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in Karnataka, India. Asian Pac J Cancer Prev. 2011;12(3):645–8.
Human Papilloma Virus ICMR: High power Committee to Evaluate Performance of ICMR, 2012–2013. New Delhi, India: ICMR; 2014. Disease Specific Documents for XII plan.
Bansal AB, Pakhare AP, Kapoor N, Mehrotra R, Kokane AM. Knowledge, attitude, and practices related to cervical cancer among adult women: a hospital-based cross-sectional study. J Nat Sci Biol Med. 2015;6(2):324–8.
Sharma J, Day P, Puroshottam R. Current understanding on HPV infection and cervical cancer along with risk factor among women of urban Delhi. Gynecol Oncol. 2013;118:S12–7.
Sanjose D, Laimins L. A meta-analytic study on pathogenesis of human papillomaviruses. Microbiol Mol Biol. 2004;68:362–72.
Liu S, Chan K, Leung R, et al. Meta-analysis on the prevalence and risk factors of Human Papillomavirus (HPV) infection. PLoS One. 2013;6:e19244.
Zhao FH, Lewkowitz AK, Hu SY, et al. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer. 2012;131:2929–38.
Shi J, Canfell K, Lew J, et al. The burden of cervical cancer in China: synthesis of the evidence. Int J Cancer. 2012;130:641–52.
Li H, Thomas D, Jin S, et al. Tubal sterilization and use of an IUD and risk of cervical cancer. J Womens Health Gend Based Med. 2000;9:303–10.
Ma X, Wang J, Cheng Y, et al. Case-control study: the relationship between dietary factors and cervical cancer. Chin J Public Health. 2005;21:312–4.
Peng H, Liu S, Mann V, et al. Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in Sichuan Province, China. Int J Cancer. 1991;47:711–6.
Wang Z, Chen Z, Wen H. Multivariate analysis of cervical cancer risk factors (100 case—control study). China Cancer. 1992;10:340–2.
Dong Y, Sasagawa T, Fang S, et al. Human papillomavirus, Chlamydia trachomatis, and other risk factors associated with cervical cancer in China. Int J Clin Oncol. 1998;3:81–7.
Zhang S, Zhao Q, Wang T, et al. Analysis of cervical cancer risk factor in Beijing 1: 3 case-control epidemiological survey. Matern Child Health Care China. 2010;25:947–9.
Zeng X. Case-control study on risk factors of cervical cancer. China Mod Med. 2012;19:169–70.
Jiang B. Analysis of risk factors related to cervical cancer and precancerous lesions. Chin Foreign Med Res. 2013;11:30–1.
Wang J, Zhou C. Epidemiological study and analysis of cervical cancer risk factors. Chin Foreign Med Res. 2014;12:79–80.
Conflict of interest
All authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sharma, M., Kapoor, C.S. Knowledge and Awareness Regarding HPV Infection and Pap Smear Screening in Reproductive Aged Females in Delhi NCR Rural Region. Indian J Gynecol Oncolog 18, 20 (2020). https://doi.org/10.1007/s40944-020-0367-1
- Cervical cancer
- Human papilloma virus (HPV)
- Pap smear